Literature DB >> 23064436

Mitochondrial dysfunction and oxidative stress in Parkinson's disease and monogenic parkinsonism.

David N Hauser1, Teresa G Hastings.   

Abstract

The pathogenic mechanisms that underlie Parkinson's disease remain unknown. Here, we review evidence from both sporadic and genetic forms of Parkinson's disease that implicate both mitochondria and oxidative stress as central players in disease pathogenesis. A systemic deficiency in complex I of the mitochondrial electron transport chain is evident in many patients with the disease. Oxidative stress caused by reactive metabolites of dopamine and alterations in the levels of iron and glutathione in the substantia nigra accompany this mitochondrial dysfunction. Recent evidence from studies on the genetic forms of parkinsonism with particular stress on DJ-1, parkin, and PINK-1 also suggest the involvement of mitochondria and oxidative stress.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23064436      PMCID: PMC3565564          DOI: 10.1016/j.nbd.2012.10.011

Source DB:  PubMed          Journal:  Neurobiol Dis        ISSN: 0969-9961            Impact factor:   5.996


  134 in total

1.  Identification of functional subclasses in the DJ-1 superfamily proteins.

Authors:  Ying Wei; Dagmar Ringe; Mark A Wilson; Mary Jo Ondrechen
Journal:  PLoS Comput Biol       Date:  2007-01-26       Impact factor: 4.475

Review 2.  Mitochondrial dysfunction in Parkinson's disease.

Authors:  A H V Schapira
Journal:  Cell Death Differ       Date:  2007-04-27       Impact factor: 15.828

3.  Evidence that glutamine, not sugar, is the major energy source for cultured HeLa cells.

Authors:  L J Reitzer; B M Wice; D Kennell
Journal:  J Biol Chem       Date:  1979-04-25       Impact factor: 5.157

4.  Role of oxidation in the neurotoxic effects of intrastriatal dopamine injections.

Authors:  T G Hastings; D A Lewis; M J Zigmond
Journal:  Proc Natl Acad Sci U S A       Date:  1996-03-05       Impact factor: 11.205

5.  Kinetic stabilization of the alpha-synuclein protofibril by a dopamine-alpha-synuclein adduct.

Authors:  K A Conway; J C Rochet; R M Bieganski; P T Lansbury
Journal:  Science       Date:  2001-11-09       Impact factor: 47.728

6.  Analysis of the trinucleotide CAG repeat from the DNA polymerase gamma gene (POLG) in patients with Parkinson's disease.

Authors:  Jan-Willem Taanman; Anthony H V Schapira
Journal:  Neurosci Lett       Date:  2004-12-08       Impact factor: 3.046

7.  Conjugates of catecholamines with cysteine and GSH in Parkinson's disease: possible mechanisms of formation involving reactive oxygen species.

Authors:  J P Spencer; P Jenner; S E Daniel; A J Lees; D C Marsden; B Halliwell
Journal:  J Neurochem       Date:  1998-11       Impact factor: 5.372

8.  Broad activation of the ubiquitin-proteasome system by Parkin is critical for mitophagy.

Authors:  Nickie C Chan; Anna M Salazar; Anh H Pham; Michael J Sweredoski; Natalie J Kolawa; Robert L J Graham; Sonja Hess; David C Chan
Journal:  Hum Mol Genet       Date:  2011-02-04       Impact factor: 6.150

9.  Glutamate uptake into astrocytes stimulates aerobic glycolysis: a mechanism coupling neuronal activity to glucose utilization.

Authors:  L Pellerin; P J Magistretti
Journal:  Proc Natl Acad Sci U S A       Date:  1994-10-25       Impact factor: 11.205

10.  Iron and aluminum increase in the substantia nigra of patients with Parkinson's disease: an X-ray microanalysis.

Authors:  E C Hirsch; J P Brandel; P Galle; F Javoy-Agid; Y Agid
Journal:  J Neurochem       Date:  1991-02       Impact factor: 5.372

View more
  145 in total

1.  PGC-1α/ERRα-Sirt3 Pathway Regulates DAergic Neuronal Death by Directly Deacetylating SOD2 and ATP Synthase β.

Authors:  Xuefei Zhang; Xiaoqing Ren; Qi Zhang; Zheyi Li; Shuaipeng Ma; Jintao Bao; Zeyang Li; Xue Bai; Liangjun Zheng; Zhong Zhang; Shujiang Shang; Chen Zhang; Chuangui Wang; Liu Cao; Qingsong Wang; Jianguo Ji
Journal:  Antioxid Redox Signal       Date:  2015-11-19       Impact factor: 8.401

Review 2.  Comparative Microarray Analysis Identifies Commonalities in Neuronal Injury: Evidence for Oxidative Stress, Dysfunction of Calcium Signalling, and Inhibition of Autophagy-Lysosomal Pathway.

Authors:  Yann Wan Yap; Roxana M Llanos; Sharon La Fontaine; Michael A Cater; Philip M Beart; Nam Sang Cheung
Journal:  Neurochem Res       Date:  2015-08-29       Impact factor: 3.996

3.  Loss of PINK1 causes age-dependent decrease of dopamine release and mitochondrial dysfunction.

Authors:  Lianteng Zhi; Qi Qin; Tanziyah Muqeem; Erin L Seifert; Wencheng Liu; Sushuang Zheng; Chenjian Li; Hui Zhang
Journal:  Neurobiol Aging       Date:  2018-11-02       Impact factor: 4.673

4.  Pre-clinical therapeutic development of a series of metalloporphyrins for Parkinson's disease.

Authors:  Li-Ping Liang; Jie Huang; Ruth Fulton; Jennifer N Pearson-Smith; Brian J Day; Manisha Patel
Journal:  Toxicol Appl Pharmacol       Date:  2017-04-08       Impact factor: 4.219

5.  Comparative analysis of Parkinson's disease-associated genes in mice reveals altered survival and bioenergetics of Parkin-deficient dopamine neurons.

Authors:  Nicolas Giguère; Consiglia Pacelli; Caroline Saumure; Marie-Josée Bourque; Diana Matheoud; Daniel Levesque; Ruth S Slack; David S Park; Louis-Éric Trudeau
Journal:  J Biol Chem       Date:  2018-04-26       Impact factor: 5.157

6.  Preferential Heme Oxygenase-1 Activation in Striatal Astrocytes Antagonizes Dopaminergic Neuron Degeneration in MPTP-Intoxicated Mice.

Authors:  Xiaofeng Xu; Ning Song; Ranran Wang; Hong Jiang; Junxia Xie
Journal:  Mol Neurobiol       Date:  2015-09-18       Impact factor: 5.590

7.  Acute exposure to a Mn/Zn ethylene-bis-dithiocarbamate fungicide leads to mitochondrial dysfunction and increased reactive oxygen species production in Caenorhabditis elegans.

Authors:  Callie E Todt; Denise C Bailey; Aireal S Pressley; Sarah E Orfield; Rachel D Denney; Isaac B Snapp; Rekek Negga; Andrew C Bailey; Kara M Montgomery; Wendy L Traynor; Vanessa A Fitsanakis
Journal:  Neurotoxicology       Date:  2016-09-20       Impact factor: 4.294

8.  Nanomicellar formulation of coenzyme Q10 (Ubisol-Q10) effectively blocks ongoing neurodegeneration in the mouse 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine model: potential use as an adjuvant treatment in Parkinson's disease.

Authors:  Marianna Sikorska; Patricia Lanthier; Harvey Miller; Melissa Beyers; Caroline Sodja; Bogdan Zurakowski; Sandhya Gangaraju; Siyaram Pandey; Jagdeep K Sandhu
Journal:  Neurobiol Aging       Date:  2014-04-02       Impact factor: 4.673

9.  Effects of Physical Rehabilitation in Patients with Spinocerebellar Ataxia Type 7.

Authors:  Karla Tercero-Pérez; Hernán Cortés; Yessica Torres-Ramos; Roberto Rodríguez-Labrada; César M Cerecedo-Zapata; Oscar Hernández-Hernández; Nelson Pérez-González; Rigoberto González-Piña; Norberto Leyva-García; Bulmaro Cisneros; Luis Velázquez-Pérez; Jonathan J Magaña
Journal:  Cerebellum       Date:  2019-06       Impact factor: 3.847

10.  Neuronal Glutathione Content and Antioxidant Capacity can be Normalized In Situ by N-acetyl Cysteine Concentrations Attained in Human Cerebrospinal Fluid.

Authors:  Reno C Reyes; Giordano Fabricio Cittolin-Santos; Ji-Eun Kim; Seok Joon Won; Angela M Brennan-Minnella; Maya Katz; Graham A Glass; Raymond A Swanson
Journal:  Neurotherapeutics       Date:  2016-01       Impact factor: 7.620

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.